Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Päivi Ruokoniemi"'
Autor:
Katri Hämeen-Anttila, Hanna M Tolonen, Marja SA Airaksinen, Päivi Ruokoniemi, Kenneth M Shermock, Pekka Kurki
Publikováno v:
BMJ Open, Vol 9, Iss 10 (2019)
Objectives To explore relevant Finnish stakeholders’ perceptions on the automatic substitution of biological medicines with particular focus on medication safety and issues that need to be considered to create an appropriate model for automatic bio
Externí odkaz:
https://doaj.org/article/95992cbfb4d04260b19aa67027ba1308
Autor:
Arja Helin-Salmivaara, Maarit J Korhonen, Petri Lehenkari, Seppo Y T Junnila, Pertti J Neuvonen, Päivi Ruokoniemi, Risto Huupponen
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48095 (2012)
OBJECTIVE: To study the association of long-term statin use and the risk of low-energy hip fractures in middle-aged and elderly women. DESIGN: A register-based cohort study. SETTING: Finland. PARTICIPANTS: Women aged 45-75 years initiating statin the
Externí odkaz:
https://doaj.org/article/e18f8aaeea7c41ac8b56a45a11238cf1
Autor:
Pekka Kurki, Jenni Falck, Katri Hämeen-Anttila, Hanna M. Tolonen, Kenneth M. Shermock, Marja Airaksinen, Päivi Ruokoniemi
Publikováno v:
Biodrugs
Background Biosimilars are expected to decrease growing health care expenditures. Given that uptake of biosimilars has been modest, automatic substitution has been suggested to increase their use, but the practice is not yet allowed or implemented in
Autor:
Atte Meretoja, Päivi Ruokoniemi, Risto Huupponen, Maarit Jaana Korhonen, Arja Helin-Salmivaara, Jenni Ilomäki
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:161-169
Purpose We aimed to quantify for the first time the relationship between statin adherence and ischemic stroke (IS) in patients with diabetes. Methods Using Finnish health registers, we assembled a cohort of 52 868 statin initiators with diabetes in 1
Autor:
Pekka Kurki, Hanna M. Tolonen, Marja Airaksinen, Päivi Ruokoniemi, Kenneth M. Shermock, Katri Hämeen-Anttila
Publikováno v:
BMJ Open
ObjectivesTo explore relevant Finnish stakeholders’ perceptions on the automatic substitution of biological medicines with particular focus on medication safety and issues that need to be considered to create an appropriate model for automatic biol
Autor:
Seppo Y. T. Junnila, Raimo Kettunen, Piia Lavikainen, Risto Huupponen, Päivi Ruokoniemi, Antti Jula, Arja Helin-Salmivaara, Maarit Jaana Korhonen
Publikováno v:
British Journal of Clinical Pharmacology. 71:766-776
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Statin therapy is recommended in diabetes to lower the risk of coronary events. However, large randomized trials of statins performed specifically among diabetic patients have produced conflicting results.
Autor:
Maarit Jaana, Korhonen, Päivi, Ruokoniemi, Jenni, Ilomäki, Atte, Meretoja, Arja, Helin-Salmivaara, Risto, Huupponen
Publikováno v:
Pharmacoepidemiology and drug safety. 25(2)
We aimed to quantify for the first time the relationship between statin adherence and ischemic stroke (IS) in patients with diabetes.Using Finnish health registers, we assembled a cohort of 52 868 statin initiators with diabetes in 1995-2006. We cond
Autor:
Pertti J. Neuvonen, Maarit Jaana Korhonen, Arja Helin-Salmivaara, Petri Lehenkari, Seppo Y. T. Junnila, Risto Huupponen, Päivi Ruokoniemi
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48095 (2012)
PLoS ONE
PLoS ONE
OBJECTIVE: To study the association of long-term statin use and the risk of low-energy hip fractures in middle-aged and elderly women. DESIGN: A register-based cohort study. SETTING: Finland. PARTICIPANTS: Women aged 45-75 years initiating statin the
Publikováno v:
European journal of clinical pharmacology. 65(11)
Autor:
Päivi Ruokoniemi, Arja Helin-Salmivaara, Piia Lavikainen, Risto Huupponen, Maarit Jaana Korhonen
Publikováno v:
Diabetes research and clinical practice. 84(1)
Persistence with statin therapy was studied among 562 598 new statin users in 1995-2005 in Finland. Discontinuation was most likely during the first year. Persons with diabetes (15.0% of initiators) were significantly more likely to continue statin t